Jeffrey W. Sherman - Jan 10, 2023 Form 4 Insider Report for Horizon Therapeutics Public Ltd Co (HZNP)

Role
EVP and Chief Medical Officer
Signature
/s/ Patrick McIlvenny, Attorney-in-Fact
Stock symbol
HZNP
Transactions as of
Jan 10, 2023
Transactions value $
-$761,673
Form type
4
Date filed
1/12/2023, 03:29 PM
Previous filing
Jan 6, 2023
Next filing
Jan 18, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HZNP Ordinary Shares Sale -$381K -3.37K -7.85% $113.05 39.5K Jan 10, 2023 Direct F1
transaction HZNP Ordinary Shares Sale -$381K -3.37K -8.52% $113.10 36.2K Jan 11, 2023 Direct F1
holding HZNP Ordinary Shares 49.3K Jan 10, 2023 See Footnote F2
holding HZNP Ordinary Shares 84.4K Jan 10, 2023 See Footnote F3
holding HZNP Ordinary Shares 66.7K Jan 10, 2023 by Spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 11, 2022.
F2 The shares are held in the Jeffrey W. Sherman Living Trust.
F3 The shares are held in the name of the Jeffrey W. Sherman 2020 Gift Trust, of which the reporting person's spouse is the Trustee.